Phase II Study of Adebrelimab, Chemotherapy, and Apatinib for Advanced Pulmonary Neuroendocrine Tumors
NCT06764368
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
39
Enrollment
OTHER
Sponsor class
Conditions
Neuroendocrine Tumors
Interventions
DRUG:
Adebrelimab + Apatinib
Sponsor
Beijing Chest Hospital